journal article·2026-06Open access

From permeation enhancer to therapeutic enabler: Advances, applications, and translational perspectives in hyaluronidase-based drug delivery

Yuna Seo, Jiyoon Sung, Jae-Young Lee

Abstract

Hyaluronidase is a carbohydrate-active enzyme that cleaves glycosaminoglycans, particularly hyaluronic acid. By transiently degrading the extracellular matrix, it facilitates reliable subcutaneous delivery of high-dose protein therapeutics. Despite its proven utility, challenges remain in preserving enzyme stability and ensuring consistent catalytic performance across formulations. Recent efforts have therefore focused on excipient and pH optimization to maintain protein integrity while sustaining enzymatic activity, device engineering to enhance injectability and patient usability, and pharmacokinetic modeling to correlate local tissue dispersion with systemic exposure. In oncology, hyaluronidase is increasingly incorporated into anticancer regimens to remodel the tumor microenvironment, alleviate stromal resistance, and promote immune-cell infiltration, thereby enabling synergistic antitumor effects across multiple therapeutic modalities. This review first classifies hyaluronidases by their biological sources and catalytic mechanisms, then summarizes advances in drug delivery with particular emphasis on recombinant human hyaluronidase in clinical use. Finally, it highlights mechanistic and translational insights that guide the rational design of safer, more effective, and clinically adaptable hyaluronidase-enabled delivery systems for both subcutaneous and tumor-targeted applications. Hyaluronidase transiently remodels the extracellular matrix to enhance drug permeability and dispersion. This review outlines advances in recombinant human hyaluronidase (rHuPH20) for subcutaneous and tumor-targeted delivery, highlighting formulation stabilization, injectability optimization, and pharmacokinetic modeling.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Proteoglycans and glycosaminoglycans research · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. The extracellular matrix at a glance10.1242/jcs.023820 ↗
2. Extracellular matrix structure10.1016/j.addr.2015.11.001 ↗
3. The content and size of hyaluronan in biological fluids and tissues10.3389/fimmu.2015.00261 ↗
4. Hyaluronidases: their genomics, structures, and mechanisms of action10.1021/cr050247k ↗
5. A mucolytic enzyme in testis extracts10.1038/144977b0 ↗
6. Exaltation de l’activité du virus vaccinal par les extraits de certains organes
7. Identity of hyaluronidase and spreading factor
8. Hyaluronidase overcomes the extracellular matrix barrier to enhance local drug delivery10.1016/j.ejpb.2024.114474 ↗
9. Stern
10. Hyaluronidase and chondroitinase
11. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview10.1016/j.lfs.2007.02.037 ↗
12. Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets10.1186/s43556-025-00299-y ↗
13. 11 hyaluronidases
14. Stereochemistry of chitin hydrolysis by a plant chitinase/lysozyme and x-ray structure of a complex with allosamidin evidence for substrate assisted catalysis10.1021/bi00048a003 ↗
15. Kinetic and mechanistic studies with bovine testicular hyaluronidase10.1016/0304-4165(94)90173-2 ↗
16. Characterization of hydrolysis and transglycosylation by testicular hyaluronidase using ion-spray mass spectrometry10.1021/bi00187a017 ↗
17. High-yield novel leech hyaluronidase to expedite the preparation of specific hyaluronan oligomers10.1038/srep04471 ↗
18. Hyaluronidase from infective Ancylostoma hookworm larvae and its possible function as a virulence factor in tissue invasion and in cutaneous larva migrans10.1128/iai.60.3.1018-1023.1992 ↗
19. Structure and cleavage pattern of a hyaluronate 3-glycanohydrolase in the glycoside hydrolase 79 family10.1016/j.carbpol.2021.118838 ↗
20. Alternate structural conformations of Streptococcus pneumoniae hyaluronan lyase: insights into enzyme flexibility and underlying molecular mechanism of action10.1016/j.jmb.2006.02.066 ↗
21. Hyaluronidases, a group of glycosidases: current and future perspectives10.1016/j.carbpol.2010.02.047 ↗
22. Insights into the source, mechanism and biotechnological applications of hyaluronidases10.1016/j.biotechadv.2022.108018 ↗
23. Purification and biochemical characterization of hyaluronidase from Egyptian Echis pyramidum pyramidum venom
24. β-elimination of hyaluronate by red king crab hyaluronidase10.1038/s41598-021-01890-3 ↗
25. Production of Vespa tropica hyaluronidase by Pichia pastoris10.3390/jof10120854 ↗
26. Cloning and biochemical characterization of a hyaluronate lyase from bacillus sp. CQMU-D10.4014/jmb.2209.09036 ↗
27. Hyaluronidase from Paenibacillus aquistagni SH-7-A: identification and characterization10.1016/j.ibiod.2023.105708 ↗
28. Identification and characterization of a highly active hyaluronan lyase from Enterobacter asburiae10.3390/md22090399 ↗
29. Cloning and characterization of a hyaluronate lyase EsHyl8 from Escherichia sp. A9910.1016/j.pep.2024.106551 ↗
30. Purification and characterization of the produced hyaluronidase by Brucella Intermedia MEFS for antioxidant and anticancer applications10.1186/s12934-024-02469-z ↗
31. Antioxidant and anti-breast cancer properties of hyaluronidase from Marine Staphylococcus aureus (CASMTK1)10.3390/jmse11040778 ↗
32. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer10.1074/jbc.M008432200 ↗
33. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors10.1002/ijc.11252 ↗
34. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q3110.1006/geno.1999.5876 ↗
35. Structure of human Hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis10.1021/bi700382g ↗
36. The degradation of hyaluronan in the skin10.3390/biom12020251 ↗
37. The six hyaluronidase-like genes in the human and mouse genomes10.1016/S0945-053X(01)00172-X ↗
38. Hyal2 — less active, but more versatile?10.1016/S0945-053X(01)00170-6 ↗
39. CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by Hyaluronidase-1 and -210.1074/jbc.M608358200 ↗
40. Expression and activity of hyaluronidases HYAL-1, HYAL-2 and HYAL-3 in the human intervertebral disc10.1007/s00586-019-06227-3 ↗
41. Hyaluronan: metabolism and function10.3390/biom10111525 ↗
42. Chain gangs: new aspects of hyaluronan metabolism10.1155/2012/893947 ↗
43. Immunological functions of hyaluronan and its receptors in the lymphatics10.1111/j.1600-065X.2009.00803.x ↗
44. A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver10.1074/jbc.M211462200 ↗
45. Emerging roles for hyaluronidase in cancer metastasis and therapy
46. Hyaluronidases in human diseases10.3390/ijms22063204 ↗
47. Transcription of the human and rodent SPAM1/PH-20 genes initiates within an ancient endogenous retrovirus10.1186/1471-2164-6-47 ↗
48. Hyaluronidases have strong hydrolytic activity toward chondroitin 4-Sulfate comparable to that for hyaluronan10.3390/biom2040549 ↗
49. The dual functions of GPI-anchored PH-20: hyaluronidase and intracellular signaling10.1016/S0945-053X(01)00171-8 ↗
50. Structural relationship of sperm soluble hyaluronidase to the sperm membrane protein PH-2010.1095/biolreprod54.6.1343 ↗
51. Identification of a hyaluronic acid (HA) binding domain in the PH-20 protein that may function in cell signaling10.1002/mrd.1119 ↗
52. Characterization of the active site of monkey sperm hyaluronidase10.1530/rep.0.1210735 ↗
53. Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation10.1016/j.matbio.2008.07.006 ↗
54. Mouse Hyal3 encodes a 45- to 56-kDa glycoprotein whose overexpression increases hyaluronidase 1 activity in cultured cells10.1093/glycob/cwn006 ↗
55. Molecular characterization of kidney cancer10.1002/cncr.26520 ↗
56. Effects of molecular weights on the bioactivity of hyaluronic acid: a review10.1016/j.carres.2025.109472 ↗
57. Central role of CEMIP in tumorigenesis and its potential as therapeutic target10.7150/jca.19295 ↗
58. Damage-associated molecular patterns in inflammatory bowel disease: from biomarkers to therapeutic targets10.3748/wjg.v24.i41.4622 ↗
59. Activated hyaluronan metabolism in the tumor matrix — causes and consequences10.1016/j.matbio.2018.04.012 ↗
60. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer10.1186/s13046-018-0771-x ↗
61. Human TMEM2 is not a catalytic hyaluronidase, but a regulator of hyaluronan metabolism via HYBID (KIAA1199/CEMIP) and HAS2 expression10.1016/j.jbc.2023.104826 ↗
62. The role and regulation of TMEM2 (transmembrane protein 2) in HYBID (hyaluronan (HA)-binding protein involved in HA depolymerization/KIAA1199/CEMIP)-mediated HA depolymerization in human skin fibroblasts10.1016/j.bbrc.2018.09.097 ↗
63. Structure of the transmembrane protein 2 (TMEM2) ectodomain and its apparent lack of hyaluronidase activity [version 2; peer review: 2 approved]
64. The hyaluronidase, TMEM2, promotes ER homeostasis and longevity independent of the UPRER10.1016/j.cell.2019.10.018 ↗
65. The cell surface hyaluronidase TMEM2 regulates cell adhesion and migration via degradation of hyaluronan at focal adhesion sites10.1016/j.jbc.2021.100481 ↗
66. The cell surface hyaluronidase TMEM2 plays an essential role in mouse neural crest cell development and survival10.1371/journal.pgen.1009765 ↗
67. Structures of vertebrate hyaluronidases and their unique enzymatic mechanism of hydrolysis10.1002/prot.20592 ↗
68. Mechanism for the hydrolysis of hyaluronan oligosaccharides by bovine testicular hyaluronidase10.1111/j.1742-4658.2010.07600.x ↗
69. Enzymic reconstruction of glycosaminoglycan oligosaccharide chains using the transglycosylation reaction of bovine testicular hyaluronidase (∗)10.1074/jbc.270.8.3741 ↗
70. Identification of the bull sperm p80 protein as a PH-20 ortholog and its modification during the epididymal transit10.1002/mrd.20308 ↗
71. Guideline for the safe use of hyaluronidase in aesthetic medicine, including modified high-dose protocol
72. Purification and characterization of a hyaluronidase from venom of the spider Vitalius dubius (Araneae, Theraphosidae)10.1186/1678-9199-20-2 ↗
73. A recombinant human enzyme for enhanced interstitial transport of therapeutics10.1016/j.jconrel.2006.05.027 ↗
74. Bee updated: current knowledge on bee venom and bee envenoming therapy10.3389/fimmu.2019.02090 ↗
75. Medicinal leech therapy—an overall perspective
76. Characterization of a hyaluronidase from Paenibacillus residui BSSK58 and evaluation of its industrial applicability10.3390/fermentation11090519 ↗
77. International standard for hyaluronidase
78. Kinetic investigation of recombinant human hyaluronidase PH20 on hyaluronic acid10.1016/j.ab.2015.04.008 ↗
79. Heparin-sepharose affinity chromatography for purification of bull seminal-plasma hyaluronidase10.1042/bj1830531 ↗
80. The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A10.1042/bj20020149 ↗
81. Structure of a group A streptococcal phage-encoded virulence factor reveals a catalytically active triple-stranded β-helix10.1073/pnas.0504782102 ↗
82. Clinical immunogenicity of rHuPH20, a hyaluronidase enabling subcutaneous drug administration10.1208/s12248-015-9782-0 ↗
83. Antihyaluronidase level in children with rheumatic fever and other streptococcal infection10.1536/ihj.17.580 ↗
84. 2024
85. Long-term safety and tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: results from the ADVANCE-CIDP 3 trial10.1111/jns.12672 ↗
86. Immunological properties of hyaluronidases associated with temperate bacteriophages of group A streptococci10.1084/jem.149.1.73 ↗
87. Snake venom hyaluronidase: a therapeutic target10.1002/cbf.1261 ↗
88. Crystal structure of hyaluronidase, a major allergen of Bee venom10.1016/S0969-2126(00)00511-6 ↗
89. Arthropod venom hyaluronidases: biochemical properties and potential applications in medicine and biotechnology10.1186/s40409-015-0042-7 ↗
90. Viper venom hyaluronidase and its potential inhibitor analysis: a multipronged computational investigation10.1080/07391102.2016.1203820 ↗
91. Comparative assessment of the allergenicity of hyaluronidases from Polistes dominula (Pol d 2), Vespula vulgaris (Ves v 2), and Apis mellifera Venom (Api m 2)10.3390/toxins16110498 ↗
92. Hyaluronidase activity in leeches (Hirudinea)10.1016/S0305-0491(99)00128-5 ↗
93. Characterisation of separated end hyaluronan oligosaccharides from leech hyaluronidase and evaluation of angiogenesis10.1016/j.carbpol.2016.01.052 ↗
94. High-level constitutive expression of leech hyaluronidase with combined strategies in recombinant Pichia pastoris10.1007/s00253-019-10282-7 ↗
95. Enhanced production of leech hyaluronidase by optimizing secretion and cultivation in Pichia pastoris10.1007/s00253-015-7056-5 ↗
96. Yeast surface display of leech hyaluronidase for the industrial production of hyaluronic acid oligosaccharides10.1016/j.engmic.2023.100086 ↗
97. Construction of engineered Streptococcus zooepidemicus for the production of hyaluronic acid ligosaccharide
98. Release of hyaluronidase during in vitro development of Ascaris suum from the third to fourth larval stage10.1007/s004360100410 ↗
99. Proteomics analysis of the excretory/secretory component of the blood-feeding stage of the hookworm, Ancylostoma caninum10.1074/mcp.M800206-MCP200 ↗
100. Degradation of hyaluronan by a Hyal2-type hyaluronidase affects pattern formation of vitelline vessels during embryogenesis of Xenopus laevis10.1016/S0925-4773(01)00593-7 ↗